BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 16687201)

  • 21. Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.
    Gómez-Palomares JL; Acevedo-Martín B; Chávez M; Manzanares M; Ricciarelli E; Hernández ER
    Fertil Steril; 2008 Mar; 89(3):620-4. PubMed ID: 17678911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of results of intrauterine insemination performed once or twice per stimulated cycle].
    Ruiz Anguas J; Anta Jaen E; Durán Monterrosas L; Kably Ambe A
    Ginecol Obstet Mex; 2005 Feb; 73(2):76-82. PubMed ID: 21961341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
    Erdem A; Erdem M; Atmaca S; Guler I
    Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrauterine insemination results in couples requiring extended semen transport time.
    Randall GW; Gantt PA
    Int J Fertil Womens Med; 2007; 52(1):28-34. PubMed ID: 17987885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preliminary results of effectiveness of two schemes of controlled ovarian hyperstimulation protocols with recombinant foliculle stimulating hormone in intrauterine insemination cycles].
    Barros Delgadillo JC; Fiszman Amora R; Santibañez Morales A; Sánchez Solis V; Gaviño Gaviño F
    Ginecol Obstet Mex; 2012 Feb; 80(2):61-72. PubMed ID: 22519213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
    Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
    J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study.
    Kocak M; Dilbaz B; Demir B; Taşci Y; Tarcan A; Dede S; Haberal A
    Gynecol Endocrinol; 2010 Jun; 26(6):429-34. PubMed ID: 20175705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: results of 4,062 intrauterine insemination cycles.
    Dickey RP; Taylor SN; Lu PY; Sartor BM; Rye PH; Pyrzak R
    Fertil Steril; 2005 Mar; 83(3):671-83. PubMed ID: 15749497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study.
    Jee BC; Ku SY; Suh CS; Kim KC; Lee WD; Kim SH
    Fertil Steril; 2006 Jun; 85(6):1774-7. PubMed ID: 16677640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination.
    Werbrouck E; Spiessens C; Meuleman C; D'Hooghe T
    Fertil Steril; 2006 Sep; 86(3):566-71. PubMed ID: 16952506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differing response to GnRH antagonists in cycles of ovarian hyperstimulation plus intrauterine insemination].
    Barros-Delgadillo JC; Trejo-Castañeda H; E-Ormsby C; Gaviño-Gaviño F
    Ginecol Obstet Mex; 2010 Jan; 78(1):15-28. PubMed ID: 20931799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination.
    Bedaiwy MA; Shokry M; Mousa N; Claessens A; Esfandiari N; Gotleib L; Casper R
    Fertil Steril; 2009 Jun; 91(6):2501-7. PubMed ID: 18501899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Controlled hyperstimulation in intra-uterine inseminations: hMG-hCG protocol (204 cycles)].
    Abboud P; Delépine B; Pigeon F; Bednarczyk L; Quéreux C
    Contracept Fertil Sex; 1997 Jun; 25(6):463-9. PubMed ID: 9280551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of double intrauterine insemination in controlled ovarian hyperstimulation cycles.
    Ragni G; Maggioni P; Guermandi E; Testa A; Baroni E; Colombo M; Crosignani PG
    Fertil Steril; 1999 Oct; 72(4):619-22. PubMed ID: 10521098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
    Mitwally MF; Casper RF
    J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.